Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Musculoskeletal Disease|August 2, 2019
Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysisKeigo Hayashi, Keiji Ohashi, Haruki Watanabe, et al.
Journal of Medical Case Reports|October 5, 2018
An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptinYoshia Miyawaki, Ken-Ei Sada, Yosuke Asano, et al.
BMC Nephrology|June 4, 2020
Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional studyEri Katsuyama, Yoshia Miyawaki, Ken-Ei Sada, et al.
Modern Rheumatology Case Reports|October 30, 2023
Infliximab biosimilar-induced lupus nephritis: A case reportKenta Shidahara, Takayuki Katsuyama, Kei Hirose, et al.
Modern Rheumatology|May 3, 2017
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositisNoriko Tatebe, Ken-Ei Sada, Yosuke Asano, et al.
Scientific Reports|March 1, 2019
Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cellsSumie Hiramatsu, Katsue S Watanabe, Sonia Zeggar, et al.
Arthritis Research & Therapy|October 13, 2020
Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studiesKen-Ei Sada, Keiji Ohashi, Yosuke Asano, et al.
Internal Medicine (Tokyo, Japan)|January 15, 2025
Dyspnea with Hemidiaphragm Elevation in a Patient with Giant Cell Arteritis: A Case ReportYosuke Asano, Yoshinori Matsumoto, Natsuki Kubota, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2023
Immunosuppressive Treatment for an anti-U<sub>1</sub> Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial HypertensionKazuya Matsumoto, Yoshia Miyawaki, Takayuki Katsuyama, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2023
Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular trapsHaruki Watanabe, Masataka Kubo, Akihiko Taniguchi, et al.
Pageof 4